Condition
Ankylosing Spondylitis clinical trials and research
As of November 12, 2026, Find a Trial lists 21 Ankylosing Spondylitis clinical trials that are recruiting, at sites in 13 countries (most in China (5), United States (5), Turkey (Türkiye) (4)). 1 was first registered in the last 30 days. By phase: Phase 3 (3), Phase 2 (2), Phase 1 (1). There are also 4 NIH-funded research projects on Ankylosing Spondylitis, with $162,540 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 21Clinical trials
- 4NIH research projects
- 1New in 30 days
- 13Countries
Newest Ankylosing Spondylitis clinical trials
All recruiting trials (21)
-
HB0017 Injection safety and PK in low-weight adults at different injection sites
This early-phase study tests a single subcutaneous HB0017 injection in healthy, low-weight adults and compares how the body processes the drug when injected at different sites.
-
Surface topography and spine damage in radiographic axial spondyloarthritis
This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.
-
New modified acupotomy method for ankylosing spondylitis
This study tests whether a modified ultrasound-guided acupotomy can reduce disease activity and symptoms in adults (18–75) with active ankylosing spondylitis (BASDAI ≥4) compared with a sham procedure.
-
How different types of low back pain affect function and quality of life in people with ankylosing spondylitis.
This single-visit project will see if different types of low back pain in adults with ankylosing spondylitis relate to pain severity, daily function, and quality of life.
-
Testing 608 in adults with active ankylosing spondylitis
This trial tests whether the medicine 608 helps adults with active ankylosing spondylitis and is safe to use.
-
LNK01001 for adults with ankylosing spondylitis
This trial will test whether taking LNK01001 twice daily helps adults with active ankylosing spondylitis reduce pain and inflammation compared with placebo.
-
Gluten-free diet effects in people with ankylosing spondylitis
This will try an 8-week gluten-free diet to see if it reduces gut leakiness and improves symptoms and function in adults with ankylosing spondylitis.
-
Evaluating neck muscles and balance in men with ankylosing spondylitis
This study is testing how the strength of neck muscles affects balance in men with ankylosing spondylitis compared to healthy men.
-
Evaluating secukinumab effectiveness in Korean patients with ankylosing spondylitis
This study is testing how well secukinumab works for Korean patients with ankylosing spondylitis who haven't tried other treatments before.
-
Identifying biomarkers for early diagnosis of inflammatory rheumatic diseases
This study is trying to find specific markers in the body that can help doctors diagnose inflammatory rheumatic diseases like Ankylosing Spondylitis, Rheumatoid Arthritis, and Systemic Lupus Erythematosus earlier and more accurately.
-
Fecal microbiota transplantation for treating axial spondyloarthritis
This study is testing if a treatment using gut bacteria from healthy donors can help people with axial spondyloarthritis who aren't feeling better with their current medications.
-
Study on how diet affects autoimmune diseases in rheumatology patients
This study looks at how changing to a healthier diet, like the Mediterranean diet, might help people with autoimmune diseases feel better and manage their symptoms.
-
Analyzing the microbiome in Korean patients with ankylosing spondylitis
This study is trying to see how the gut bacteria of Korean patients with ankylosing spondylitis might be connected to their condition by collecting and analyzing samples from them and their families.
-
Comparing Jitongning tablets to placebo for treating spondyloarthritis
This study is testing if Jitongning tablets can help people with active ankylosing spondylitis feel better compared to a placebo.
-
Registry for evaluating a comprehensive approach to autoimmune disorders
This study is testing a personalized treatment program for people with autoimmune disorders to see if combining different therapies helps them feel better over time.
-
Long-term follow-up on shoulder arthroplasty outcomes
This study is looking at how well shoulder replacement surgery works over time by following patients for at least 10 years to see how they feel and how their shoulders are doing.
-
Using capsule fecal microbiota transplantation to treat newly diagnosed chronic inflammatory diseases
This study is testing if taking capsules containing healthy gut bacteria can help people recently diagnosed with chronic inflammatory diseases feel better.
-
Educational tool for melanoma patients with autoimmune diseases
This study is testing a new educational tool to help melanoma patients with autoimmune diseases understand their treatment options better and see how easy it is for them to use.
-
Registry and biorepository for rheumatic diseases
This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.
-
Analyzing gut bacteria in patients with spondyloarthritis receiving treatment
This study is trying to see how gut bacteria might affect how well people with spondyloarthritis respond to a specific treatment.
-
Registry for patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving biologics
This study is collecting information from patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis who are using biologic treatments to see how these medications work in real life.
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
CARD9 and Ankylosing Spondylitis: understanding immune signals in veterans
A study with veterans who have ankylosing spondylitis will explore how immune signals linked to CARD9 may influence disease and treatment responses.
-
How the gene CARD9 may affect ankylosing spondylitis
Researchers are looking at whether differences in a gene called CARD9 help explain inflammation and treatment response in people with ankylosing spondylitis.
-
Understanding how spinal disease progresses in ankylosing spondylitis
This study is looking at how ankylosing spondylitis affects the spine over time, and it aims to find specific markers in your blood that can help predict how severe the damage might get, so we can catch problems early and take better care of you.
-
Investigating the role of CARD9 in Ankylosing Spondylitis
This study is looking at how genes and immune cells affect Ankylosing Spondylitis in veterans, with the goal of finding better ways to predict and personalize treatments for this painful condition.
Related topics
Quick answers
How many Ankylosing Spondylitis clinical trials are recruiting right now?
21, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in China (5 trials), United States (5 trials), Turkey (Türkiye) (4 trials), South Korea (3 trials), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.